717 related articles for article (PubMed ID: 30430731)
1. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
[TBL] [Abstract][Full Text] [Related]
2. The Synergistic Effect of TNFA and IL10 Promoter Polymorphisms on Genetic Predisposition to Systemic Lupus Erythematosus.
Manolova I; Miteva L; Ivanova M; Kundurzhiev T; Stoilov R; Stanilova S
Genet Test Mol Biomarkers; 2018 Feb; 22(2):135-140. PubMed ID: 29298134
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response.
Schotte H; Gaubitz M; Willeke P; Tidow N; Assmann G; Domschke W; Schlüter B
Rheumatology (Oxford); 2004 Nov; 43(11):1357-63. PubMed ID: 15304673
[TBL] [Abstract][Full Text] [Related]
4. Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.
Palafox-Sánchez CA; Oregon-Romero E; Salazar-Camarena DC; Valle YM; Machado-Contreras JR; Cruz A; Orozco-López M; Orozco-Barocio G; Vázquez-Del Mercado M; Muñoz-Valle JF
Clin Exp Med; 2015 Nov; 15(4):439-46. PubMed ID: 25253090
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus.
Sung YK; Park BL; Shin HD; Kim LH; Kim SY; Bae SC
Rheumatology (Oxford); 2006 Apr; 45(4):400-4. PubMed ID: 16287924
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of interleukin 6 and interleukin 10 in Egyptian patients with systemic lupus eythematosus.
Talaat RM; Alrefaey SA; Bassyouni IH; Ashour ME; Raouf AA
Lupus; 2016 Mar; 25(3):255-64. PubMed ID: 26568585
[TBL] [Abstract][Full Text] [Related]
7. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus.
Chong WP; Ip WK; Wong WH; Lau CS; Chan TM; Lau YL
Genes Immun; 2004 Sep; 5(6):484-92. PubMed ID: 15295621
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus.
Suárez A; López P; Mozo L; Gutiérrez C
Ann Rheum Dis; 2005 Nov; 64(11):1605-10. PubMed ID: 15800006
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
Rianthavorn P; Chokedeemeeboon C; Deekajorndech T; Suphapeetiporn K
Lupus; 2013 Jun; 22(7):721-6. PubMed ID: 23640982
[TBL] [Abstract][Full Text] [Related]
10. Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.
Fathi F; Sadeghi E; Lotfi N; Hafezi H; Ahmadi M; Mozafarpoor S; Motedayyen H
Int J Immunogenet; 2020 Feb; 47(1):57-64. PubMed ID: 31565862
[TBL] [Abstract][Full Text] [Related]
11. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women.
Datta A; Tuz Zahora F; Abdul Aziz M; Sarowar Uddin M; Ferdous M; Shalahuddin Millat M; Shahid Sarwar M; Abdul Barek M; Jafrin S; Nahar S; Safiqul Islam M
Int Immunopharmacol; 2020 Dec; 89(Pt B):107091. PubMed ID: 33069925
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes.
Rood MJ; Keijsers V; van der Linden MW; Tong TQ; Borggreve SE; Verweij CL; Breedveld FC; Huizinga TW
Ann Rheum Dis; 1999 Feb; 58(2):85-9. PubMed ID: 10343522
[TBL] [Abstract][Full Text] [Related]
13. IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.
Liu P; Song J; Su H; Li L; Lu N; Yang R; Peng Z
PLoS One; 2013; 8(7):e69547. PubMed ID: 23936042
[TBL] [Abstract][Full Text] [Related]
14. The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients.
Mousa TG; Omar HH; Emad R; Salama MI; Omar W; Fawzy M; Hassoba HM
Clin Rheumatol; 2019 Mar; 38(3):777-784. PubMed ID: 30374748
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.
Rosado S; Rua-Figueroa I; Vargas JA; Garcia-Laorden MI; Losada-Fernandez I; Martin-Donaire T; Perez-Chacon G; Rodriguez-Gallego C; Naranjo-Hernandez A; Ojeda-Bruno S; Citores MJ; Perez-Aciego P
Int J Immunogenet; 2008 Jun; 35(3):235-42. PubMed ID: 18397303
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 gene polymorphisms in systemic lupus erythematosus: relation to disease status.
Fouad NA; Baraka EA; Hassan WA
Egypt J Immunol; 2014; 21(1):1-12. PubMed ID: 25204040
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus.
Godarzi EM; Sarvestani EK; Aflaki E; Amirghofran Z
Clin Rheumatol; 2011 Feb; 30(2):179-84. PubMed ID: 20383729
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.
Pasha HF; Tantawy EA; Youssef MA
Gene; 2019 Jun; 702():107-113. PubMed ID: 30898714
[TBL] [Abstract][Full Text] [Related]
19. Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus.
Alesaeidi S; Karami J; Mahmoudi M; Akbarian M; Poursani S; Amirzadeh A; Haddadi NS; Saffari E; Jamshidi AR
Inflammation; 2015 Dec; 38(6):2185-90. PubMed ID: 26156810
[TBL] [Abstract][Full Text] [Related]
20. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.
Zidi S; Gazouani E; Stayoussef M; Mezlini A; Ahmed SK; Yacoubi-Loueslati B; Almawi WY
Cytokine; 2015 Dec; 76(2):343-347. PubMed ID: 26076679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
